NCT00201123View on ClinicalTrials.gov

Effects of Interferon-Gamma on Cavitary Pulmonary Tuberculosis in the Lungs

PHASE2CompletedINTERVENTIONAL
Enrollment

89

Participants

Timeline

Start Date

April 30, 2005

Primary Completion Date

January 31, 2007

Study Completion Date

August 31, 2007

Conditions
TuberculosisAIDS-related Complex
Interventions
DRUG

Aerosol Interferon-Gamma

Participants will receive aerosol interferon-gamma.

DRUG

Subcutaneous interferon-gamma

Patients will receive subcutaneous interferon-gamma

OTHER

Placebo

Trial Locations (2)

10016

NYU School of Medicine, New York

Unknown

The Lung Institute at University of Cape Town, Cape Town

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

NYU Langone Health

OTHER

NCT00201123 - Effects of Interferon-Gamma on Cavitary Pulmonary Tuberculosis in the Lungs | Biotech Hunter | Biotech Hunter